Kamyar Kalantar-Zadeh M.D. to Cost-Benefit Analysis
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Cost-Benefit Analysis.
Connection Strength
0.761
-
Kidney health for everyone everywhere - from prevention to detection and equitable access to care. Clin Nephrol. 2020 Mar; 93(3):111-122.
Score: 0.165
-
Kidney Health for Everyone Everywhere, from Prevention to Detection and Equitable Access to Care. Iran J Kidney Dis. 2020 03; 14(2):69-80.
Score: 0.165
-
The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD. J Med Econ. 2020 Mar; 23(3):308-315.
Score: 0.162
-
Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care. Nephron. 2020; 144(4):162-169.
Score: 0.041
-
Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis. Forum Health Econ Policy. 2020 03 05; 23(1).
Score: 0.041
-
Kidney health for everyone everywhere-From prevention to detection and equitable access to care. Nephrology (Carlton). 2020 03; 25(3):195-201.
Score: 0.041
-
Kidney Health for Everyone Everywhere - From prevention to detection and equitable access to care. Nefrologia (Engl Ed). 2020 Mar - Apr; 40(2):133-141.
Score: 0.041
-
Kidney health for everyone everywhere - from prevention to detection and equitable access to care. Saudi J Kidney Dis Transpl. 2020 Mar-Apr; 31(2):298-311.
Score: 0.041
-
Kidney health for everyone, everywhere: from prevention to detection and equitable access to care. Intern Med J. 2020 02; 50(2):145-150.
Score: 0.041
-
Peritoneal dialysis: an underutilized modality. Curr Opin Nephrol Hypertens. 2010 Nov; 19(6):573-7.
Score: 0.022